Search Results 1441-1450 of 17154 for monoclonal antibody

  1. Publications - Ricardo D. Parrondo, M.D. - Mayo Clinic

    Incidence, risk factors, and outcomes of patients with monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia who develop venous thromboembolism.

  2. Clinical trials - Oncology (Medical)

    ... antibodies and the factors that may determine disease progression and treatment response. Pagination Clinical studies. PrevPrevious Page · Go to page 1919 · Go ...

  3. Study of Two Doses of MK-3475 (Pembrolizumab) Versus Docetaxel in Previously-Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010) - Mayo Clinic

    ... antibody (including ipilimumab or any other antibody or drug specifically targeting T-cell co-stimulation or checkpoint pathways), or took part in another ...

  4. Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients with Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorder - Mayo Clinic

    Antibodies: ≥ 21 days must have elapsed from infusion of last dose of antibody, and toxicity related to prior antibody therapy must be recovered to grade ≤ 1; ...

  5. Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations - Mayo Clinic

    An investigational agent or anticancer therapy (including Tumor Treating Fields) within 2 weeks, or investigational monoclonal antibody within 4 weeks prior to ...

  6. A Study of Markers in the Blood and/or Stored Kidney Biopsy Tissue in Patients with a History of Childhood Onset of Membranous Nephropathy - Mayo Clinic

    By collecting health information and laboratory samples, our goal is to learn more about membranous nephropathy. Due to discovery of additional antibodies and ...

  7. Clinical Trial of SP-2577 (Seclidemstat) in Patients With Relapsed or Refractory Ewing or Ewing-related Sarcomas - Mayo Clinic

    Other, prior systemic anti-cancer treatment (chemotherapy or biologic therapy [i.e., monoclonal antibodies]) within 21 days prior to Cycle 1 Day 1. For ...

  8. Study of E7386 in Participants With Selected Advanced Neoplasms - Mayo Clinic

    For drugs such as monoclonal antibodies with half-lives > 10 days, at least 56 days is required.. - Use of any live vaccines (example, intranasal influenza ...

  9. Study of Pomalidomide for Treatment of Relapsed/Refractory Primary Central Nervous System Lymphoma and Newly Diagnosed or Relapsed/Refractory Intraocular Lymphoma - Mayo Clinic

    ... antibody (HBcIgM Ab), hepatitis B surface antigen (HBsAg) and hepatitis C antibody screen (HCV Ab Scrn) w/Reflex testing are required at screening for all ...

  10. Shortness of breath Causes - Mayo Clinic

    Monoclonal antibody drugs · Mort Crim and Cancer · Mouth sores caused by cancer treatment: How to cope · MRI: Is gadolinium safe for people with kidney problems ...